Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 1
1990 1
1991 1
1993 1
1994 1
1998 3
1999 4
2000 1
2001 1
2002 4
2003 19
2004 24
2005 15
2006 14
2007 24
2008 19
2009 14
2010 18
2011 12
2012 20
2013 15
2014 13
2015 13
2016 10
2017 11
2018 22
2019 16
2020 15
2021 11
2022 18
2023 23
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

351 results

Results by year

Filters applied: . Clear all
Page 1
Mitochondria-ER contact mediated by MFN2-SERCA2 interaction supports CD8+ T cell metabolic fitness and function in tumors.
Yang JF, Xing X, Luo L, Zhou XW, Feng JX, Huang KB, Liu H, Jin S, Liu YN, Zhang SH, Pan YH, Yu B, Yang JY, Cao YL, Cao Y, Yang CY, Wang Y, Zhang Y, Li J, Xia X, Kang T, Xu RH, Lan P, Luo JH, Han H, Bai F, Gao S. Yang JF, et al. Among authors: cao yl. Sci Immunol. 2023 Sep 29;8(87):eabq2424. doi: 10.1126/sciimmunol.abq2424. Epub 2023 Sep 22. Sci Immunol. 2023. PMID: 37738362
Nanodevices for deep cartilage penetration.
Xu XL, Xue Y, Ding JY, Zhu ZH, Wu XC, Song YJ, Cao YL, Tang LG, Ding DF, Xu JG. Xu XL, et al. Among authors: cao yl. Acta Biomater. 2022 Dec;154:23-48. doi: 10.1016/j.actbio.2022.10.007. Epub 2022 Oct 12. Acta Biomater. 2022. PMID: 36243371 Review.
Plasma circRNAs as Biomarkers in Cancer.
Zhou Q, Ju LL, Ji X, Cao YL, Shao JG, Chen L. Zhou Q, et al. Among authors: cao yl. Cancer Manag Res. 2021 Sep 21;13:7325-7337. doi: 10.2147/CMAR.S330228. eCollection 2021. Cancer Manag Res. 2021. PMID: 34584458 Free PMC article. Review.
Flavonoids in Treatment of Chronic Kidney Disease.
Cao YL, Lin JH, Hammes HP, Zhang C. Cao YL, et al. Molecules. 2022 Apr 6;27(7):2365. doi: 10.3390/molecules27072365. Molecules. 2022. PMID: 35408760 Free PMC article. Review.
Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study in multiple populations.
Lin GW, Xu C, Chen K, Huang HQ, Chen J, Song B, Chan JKC, Li W, Liu W, Shih LY, Chuang WY, Kim WS, Tan W, Peng RJ, Laurensia Y, Cheah DMZ, Huang D, Cheng CL, Su YJ, Tan SY, Ng SB, Tang TPL, Han K, Wang VY, Jia WH, Pei Z, Li YJ, Gao S, Shi Y, Hu Z, Zhang F, Zhang B, Zeng YX, Shen H, He L, Ong CK, Lim ST, Chanock S, Kwong YL, Lin D, Rothman N, Khor CC, Lan Q, Bei JX; International NKTCL Working Group. Lin GW, et al. Lancet Oncol. 2020 Feb;21(2):306-316. doi: 10.1016/S1470-2045(19)30799-5. Epub 2019 Dec 23. Lancet Oncol. 2020. PMID: 31879220
A phase III randomized, double-blind, placebo-controlled trial of the denosumab biosimilar QL1206 in postmenopausal Chinese women with osteoporosis and high fracture risk.
Zhang H, Gu JM, Chao AJ, Cheng Q, Teng DH, Yu JM, Wang BW, Huo YN, Mao L, Zhang Q, Yang H, Yan SG, Zhang KQ, Zhao XL, Lin H, Pei Y, Yuan Z, Dai RC, He L, Chen L, Su YF, Deng ZL, You L, Ban B, Zhu M, Cao YL, Zhu YK, Li ZJ, Zhang Z, Yi CQ, Lu YB, Wang G, Han CC, Wang ZJ, Li XX, Zhang ZL. Zhang H, et al. Among authors: cao yl. Acta Pharmacol Sin. 2023 Feb;44(2):446-453. doi: 10.1038/s41401-022-00954-y. Epub 2022 Jul 27. Acta Pharmacol Sin. 2023. PMID: 35896694 Free PMC article. Clinical Trial.
Tissue-engineered nipple reconstruction.
Cao YL, Lach E, Kim TH, Rodríguez A, Arévalo CA, Vacanti CA. Cao YL, et al. Plast Reconstr Surg. 1998 Dec;102(7):2293-8. doi: 10.1097/00006534-199812000-00002. Plast Reconstr Surg. 1998. PMID: 9858161
351 results